Saladax Biomedical actively pursues strategic alliances for co-promotion and/or distribution of its proprietary line of MyCare™ products. We seek leaders in the in-vitro diagnostic industry that market instrument platforms on which MyCare tests will be performed, major reference laboratories that would offer MyCare testing services, and pharmaceutical companies that market anticancer drugs that would further enhance patient outcomes via the Saladax MyCare technology platform.
June 2010
Saladax entered into a multi-year development and commercialization agreement with Bristol-Myers Squibb Company (NYSE: BMY ) for the development of certain clinical diagnostic tests to be used in conjunction with the development of certain therapeutic compounds in the Bristol-Myers Squibb pipeline. (Read More)
April 2010
Saladax Biomedical, Inc. executed an exclusive distribution agreement with FALCO SD HOLDINGS Co., Ltd. of Kyoto, Japan (www.web.falco.co.jp/english) for the Saladax My5-FU test kit in the Japanese market. (Read More)
October 2008
Saladax finalized an agreement with Roche Diagnostics (SWISS: RO.SW, www.roche.com) for the distribution of the Roche cobas c 111 analyzer which serves as a delivery platform for all Saladax MyCare assays currently under development.
September 2008
Saladax announced the finalization of an exclusive North American licensing agreement with Myriad Genetics (Nasdaq: MYGN, www.myriad.com) for the My5-FU technology, enabling Myriad to offer 5-FU dose management testing services under the trade name OnDose™. (Read More). Myriad subsequently launched the My5-FU Assay under the trade name OnDose™. (Read More).
“Our ability to attract industry leaders as collaborators attests to the continued success of Saladax Biomedical. With a robust pipeline of proprietary products, we will continue to actively seek partnerships to assure the long-term success of our portfolio.”
Partnering contact:
Edward L. Erickson
President & CEO
Saladax Biomedical, Inc.
116 Research Drive
Bethlehem, PA 18015
E-mail: eerickson@saladax.com
Phone: (610) 419-6731 ext. 26533
Fax: (610) 849-5001